Table S1 shows cancer-attributable annualized average costs for oral prescription drugs by Part D low income subsidy status
No takes yet. Share an insight, caveat, or question.
Mariotto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: